Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26310308)

Published in J Infect Dis on August 26, 2015

Authors

Peter J Kuebler1, Megha L Mehrotra2, Brian I Shaw1, Kaitlyn S Leadabrand1, Jeffrey M Milush1, Vanessa A York1, Patricia Defechereux2, Robert M Grant3, Esper G Kallás4, Douglas F Nixon5

Author Affiliations

1: Division of Experimental Medicine, University of California-San Francisco.
2: Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, California.
3: Department of Medicine, University of California-San Francisco Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, California.
4: Division of Clinical Immunology and Allergy, University of São Paulo, Brazil.
5: Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington D.C.

Associated clinical trials:

Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men | NCT00458393

Articles cited by this

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood (2004) 7.09

Glycerol monolaurate prevents mucosal SIV transmission. Nature (2009) 5.02

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis (2014) 3.65

Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87

Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis (2011) 2.35

Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology (2006) 1.64

Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol (2005) 1.56

Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection. AIDS (2004) 1.11

Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr (2013) 1.11

Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J Infect Dis (2000) 1.09

Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals. J Immunol (2010) 0.99

Early immunologic and virologic predictors of clinical HIV-1 disease progression. AIDS (2013) 0.90

CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children. AIDS (2013) 0.87

Cellular human immunodeficiency virus (HIV)-protective factors: a comparison of HIV-exposed seronegative female sex workers and female blood donors in Abidjan, Côte d'Ivoire. J Infect Dis (2002) 0.86